BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 24280439)

  • 21. Adjunct use of optical coherence tomography increases the detection of recurrent basal cell carcinoma over clinical and dermoscopic examination alone.
    Hussain AA; Themstrup L; Nürnberg BM; Jemec G
    Photodiagnosis Photodyn Ther; 2016 Jun; 14():178-84. PubMed ID: 27109055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
    Tyrrell JS; Morton C; Campbell SM; Curnow A
    Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer.
    Christensen E; Warloe T; Kroon S; Funk J; Helsing P; Soler AM; Stang HJ; Vatne O; Mørk C;
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):505-12. PubMed ID: 19807828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
    Caekelbergh K; Annemans L; Lambert J; Roelandts R
    Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical coherence tomography imaging of basal cell carcinoma undergoing photodynamic therapy: A pilot study.
    Niculescu L; Bierhoff E; Hartmann D; Ruzicka T; Berking C; Braunmühl TV
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():133-137. PubMed ID: 28179181
    [No Abstract]   [Full Text] [Related]  

  • 27. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
    Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
    Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
    Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
    Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
    Fai D; Romano I; Fai C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes.
    Caekelbergh K; Nikkels AF; Leroy B; Verhaeghe E; Lamotte M; Vincent R
    J Drugs Dermatol; 2009 Nov; 8(11):992-6. PubMed ID: 19894366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
    Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
    Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
    Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
    Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate.
    Alique-García S; Company-Quiroga J; Sánchez Campos A; Hernández Núñez A; Borbujo J
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():190-192. PubMed ID: 30914392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
    Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
    Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.
    Braathen LR; Paredes BE; Saksela O; Fritsch C; Gardlo K; Morken T; Frølich KW; Warloe T; Solér AM; Ros AM
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):550-5. PubMed ID: 19415804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
    Jerjes W; Hamdoon Z; Hopper C
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery combined with photodynamic therapy versus surgery alone for the treatment of non-melanoma skin cancer and actinic keratosis: A retrospective cohort study.
    Yang W; Liu L; Yang W; Wang D
    Dermatol Ther; 2022 Aug; 35(8):e15652. PubMed ID: 35716107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.